Literature DB >> 9917672

Patient comorbidity: relationship to outcomes of total knee arthroplasty.

R C Wasielewski1, H Weed, C Prezioso, C Nicholson, R D Puri.   

Abstract

One hundred six patients treated consecutively with total knee arthroplasty were evaluated to determine whether preoperative comorbidity (as measured by patient class, knee score, short form, anesthesia severity assessment, and number of medical comorbidities) correlated with perioperative and postoperative outcomes, including length of stay, total (and specific) hospital charges, and validated outcome scores. The length of stay for total knee arthroplasty was longer in patients who had lower preoperative knee scores and for patients with greater medical and musculoskeletal morbidity. Greater total hospital costs were associated with Class C patients and patients with poor anesthesia morbidity ratings. Patients who were debilitated medically and had four or more risk factors had decreased postoperative outcome scores. Preoperative medical and musculoskeletal morbidity influence the results of total knee arthroplasty. These findings may be useful to surgeons for optimizing resource utilization and outcomes in patients undergoing total knee arthroplasty. These data must be accounted for when contrasting total knee arthroplasty results between different surgeons and institutions.

Entities:  

Mesh:

Year:  1998        PMID: 9917672

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  23 in total

1.  Component alignment in simultaneous bilateral or unilateral total knee arthroplasty.

Authors:  Volkan Kilincoglu; Koray Unay; Kaya Akan; Irfan Esenkaya; Oguz Poyanli
Journal:  Int Orthop       Date:  2010-03-18       Impact factor: 3.075

2.  Insurance Payer Type and Patient Income Are Associated with Outcomes after Total Shoulder Arthroplasty.

Authors:  Jasvinder A Singh; John D Cleveland
Journal:  J Rheumatol       Date:  2019-06-01       Impact factor: 4.666

3.  The Elixhauser comorbidity method outperforms the Charlson index in predicting inpatient death after orthopaedic surgery.

Authors:  Mariano E Menendez; Valentin Neuhaus; C Niek van Dijk; David Ring
Journal:  Clin Orthop Relat Res       Date:  2014-05-28       Impact factor: 4.176

4.  Age, race, comorbidity, and insurance payer type are associated with outcomes after total ankle arthroplasty.

Authors:  Jasvinder A Singh; John D Cleveland
Journal:  Clin Rheumatol       Date:  2019-11-18       Impact factor: 2.980

5.  Increasing financial burden of revision total knee arthroplasty.

Authors:  Kayode O Oduwole; Diarmuid C Molony; Ray J Walls; Simi P Bashir; Kevin J Mulhall
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2010-02-11       Impact factor: 4.342

6.  Length of stay and its impact upon functional outcomes following lower limb arthroplasty.

Authors:  Timothy M Brock; Paul N Baker; Steven Rushton; Michelle Bardgett; David Deehan
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2015-12-30       Impact factor: 4.342

7.  Does preoperative American Society of Anesthesiologists score relate to complications after total shoulder arthroplasty?

Authors:  Christine C Johnson; Sonal Sodha; Juan Garzon-Muvdi; Steve A Petersen; Edward G McFarland
Journal:  Clin Orthop Relat Res       Date:  2013-12-10       Impact factor: 4.176

8.  Medical and psychological comorbidity predicts poor pain outcomes after total knee arthroplasty.

Authors:  Jasvinder A Singh; David G Lewallen
Journal:  Rheumatology (Oxford)       Date:  2013-01-15       Impact factor: 7.580

9.  Effect of comorbidity on quality of life of male veterans with prevalent primary total knee arthroplasty.

Authors:  Jasvinder A Singh
Journal:  Clin Rheumatol       Date:  2009-05-17       Impact factor: 2.980

10.  Predictors of moderate-severe functional limitation after primary Total Knee Arthroplasty (TKA): 4701 TKAs at 2-years and 2935 TKAs at 5-years.

Authors:  J A Singh; M O'Byrne; S Harmsen; D Lewallen
Journal:  Osteoarthritis Cartilage       Date:  2009-12-21       Impact factor: 6.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.